Ichnos Glenmark Innovation's cancer drug ISB 2001 shows promising results in Phase 1 trial, to be presented at ASH.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback